News & Events
News
Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience, Named to PharmaVOICE 100
BOSTON AND NEW YORK - AUGUST 03, 2020 LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
LaVoieHealthScience Forms Strategic Alliance with Bioscience Valuation BSV GmbH
BOSTON/NEW YORK/GRAINAU, GERMANY – June 22, 2020 — LaVoieHealthScience (“LHS”) and Bioscience Valuation BSV GmbH (“BSV”) today announced a strategic alliance between the two firms. The alliance...
JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020
Access the event and schedule of presenting companies at virtualinvestorsummit.com Live audio webcast presentations and interactive Q&A Company presentations will be held from 10 AM-12 PM ET and...
LaVoieHealthScience Announces Promotions, Makes Additional Hires & Launches New Branding and Website
BOSTON/NEW YORK — February 20, 2020 — LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
Events
Our event calendar includes select industry, medical and investor conferences that LHS and clients will attend throughout the year.
LaVoieHealthScience Blog
Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?
And is your company prepared for what may be coming next? As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions...
15 Slides to a Powerful Corporate Presentation
As a communications agency serving the biotech, pharmaceutical, and affiliated health science industry for over 20 years, LaVoieHealthScience has developed specific guidance for clients on how to...
10 JP Morgan Week Survival Tips #JPM2020
Start reaching out if you have not already to top targetsSpread a wide net. Extend your reach and target 20% or more new names. 2x outreach + personal emails. Master schedule, one pen....
What Life Science Innovators Need to Know About MiFID II for Capital Access and Research Coverage
The EU’s signature framework for the financial markets is starting to have major impacts in the US What are the challenges and potential opportunities for companies in the life sciences? On January...
Partner with us to build your winning company
Our experienced, multi-disciplined team provides seamless integrated communications, offering strategy consulting, investor and corporate communications and public relations/marketing.